1. Home
  2. SCYX vs GAIA Comparison

SCYX vs GAIA Comparison

Compare SCYX & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$3.79

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Gaia Inc.

GAIA

Gaia Inc.

BUY

Current Price

$1.43

Market Cap

31.8M

ML Signal

BUY

Company Overview

Basic Information
Metric
SCYX
GAIA
Founded
1999
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
31.8M
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
SCYX
GAIA
Price
$3.79
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
★ $36.33
$3.88
AVG Volume (30 Days)
★ 284.7K
89.2K
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.36
18.18
EPS
N/A
★ N/A
Revenue
$257,000.00
★ $4,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$977.86
$0.32
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 12.50
52 Week Low
$0.66
$1.16
52 Week High
$6.09
$5.62

Technical Indicators

Market Signals
Indicator
SCYX
GAIA
Relative Strength Index (RSI) 39.78 45.29
Support Level $3.53 $1.18
Resistance Level $4.30 $1.79
Average True Range (ATR) 0.23 0.09
MACD -0.02 0.01
Stochastic Oscillator 23.92 48.00

Price Performance

Historical Comparison
SCYX
GAIA

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: